Skip to main content
. 2023 Jan 29;11(2):293. doi: 10.3390/vaccines11020293
ANOVA analysis of variance
BMI body mass index
COPD chronic obstructive lung disease
COVID-19 coronavirus disease 2019
HIV/AIDS human immunodeficiency virus/acute immunodeficiency syndrome
LMICs low- and middle-income countries
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2
SPO2 saturation of peripheral oxygen